Contraceptive Technology Update – June 1, 2016
June 1, 2016
View Issues
-
Zika Virus Update — What Do Your Patients Need to Know?
Approximately four in 10 (42%) U.S. adults in households in which someone is pregnant or considering becoming pregnant don’t realize the Zika virus can be sexually transmitted, according to results from a new national survey. The poll is part of an ongoing series of surveys focused on the public’s response to public health emergencies by the Harvard Opinion Research Program at the Boston-based Harvard T.H. Chan School of Public Health.
-
What’s in the Pipeline? Science Moves Long-acting Contraceptive Options Forward
With the growth in interest in long-acting reversible contraceptive methods, what new options may be available to U.S. women?
-
FDA Updates Mifepristone Labeling, Easing Access to Abortion Pill
The Food and Drug Administration has approved new and updated labeling for the medication abortion drug mifepristone (Mifeprex, Danco Laboratories, New York City) to reflect the most current clinical practices and safety and efficacy data. The drug’s new label reduces the size of the initial dose and extends the window for taking it to 70 days since the first day of a woman’s last menstrual period.
-
Review reproductive health considerations for women with inflammatory bowel disease
Between 1 and 1.4 million people in the United States have inflammatory bowel disease, a group of conditions that includes Crohn’s disease and ulcerative colitis. For women of childbearing age with IBD, there are considerations related to fertility and pregnancy, according to recent information presented by the Association of Reproductive Health Professionals.
-
Do Teen LARC Users Get Message on Condom Use?
Family planning providers are seeing an increase in adolescent use of long-acting reversible contraceptive methods. Efforts to improve LARC access to adolescents seeking contraception at Title X service sites have increased their use.
-
In Memoriam: Ward Cates Jr., MD, MPH
Ward Cates Jr., MD, MPH, one of the co-authors of Contraceptive Technology, died March 17, 2016, in Chapel Hill, NC. Cates was president emeritus and distinguished scientist at FHI 360, a global nonprofit human development organization based in Durham, NC.
-
Initiating Contraceptive Provision with Teens
Sexuality is a natural and important part of human growth for young people and a developmental milestone. Statistics from the 2013 Youth Risk Behavior Surveillance System show that 47% of students report they ever have had sex, yet only 19% of those teens reported using birth control pills, and 5% reported using the contraceptive shot, contraceptive vaginal ring, or a long-acting reversible contraceptive method (implant or intrauterine device), at last sex.
-
Can Providers Create an HPV-free Zone? Communication and Scheduling are Key
Once you administer that first shot of the human papillomavirus vaccine, what are you doing to ensure that patients receive all three doses?
-
Online ‘Pop Quiz’ Might Help Predict Sexually Transmitted Infections in Young Women
Researchers at the Baltimore-based Johns Hopkins University say an online “pop quiz” they developed in 2009 shows promising accuracy in predicting sexually transmitted infections in young women, although not apparently in young men.
-
Use Online Resources from ARHP for HPV Patient and Provider Education
The Association of Reproductive Health Professionals offers a wide range of online resources on the human papillomavirus to help clinicians stay current on prevention and treatment, as well as to provide education to their patients.